NCT03939364 - This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions | Biotech Hunter

Timeline

Start Date

January 31, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

May 31, 2023

Conditions

Leukoplakia, Oral

Interventions

DRUG

SBS-101

Isotretinoin Oral-Adhesive Film

DRUG

Placebo

Trial Locations (5)

PennState Health Milton S. Hershey Medical Center, Hershey

Carolinas Center for Oral Health, Charlotte

University of Alabama at Birmingham (UAB) - The Kirklin Clinic (TKC), Birmingham

University of Texas Southwestern Medical Center - Oral & Maxillofacial Surgery Clinic, Dallas

Brigham and Women's Hospital, Boston